Estrogen action in neuroprotection and brain inflammation - PubMed (original) (raw)
Review
Estrogen action in neuroprotection and brain inflammation
Silvia Pozzi et al. Ann N Y Acad Sci. 2006 Nov.
Abstract
The fertile period of women's life compared to menopause is associated with a lower incidence of degenerative inflammatory diseases. In brain, estrogens ameliorate brain performance and have positive effects on selected neural pathologies characterized by a strong inflammatory component. We thus hypothesized that the inflammatory response is a target of estrogen action; several studies including ours provided strong evidence to support this prediction. Microglia, the brain's inflammatory cells, and circulating monocytes express the estrogen receptors ER-alpha and ER-beta and their responsiveness in vivo and in vitro to pro-inflammatory agents, such as lipopolysaccharide (LPS), is controlled by 17beta-estradiol (E(2)). Susceptibility of central nervous system (CNS) macrophage cells to E(2) is also preserved in animal models of neuroinflammatory diseases, in which ER-alpha seems to be specifically involved. At the molecular level, induction of inflammatory gene expression is blocked by E(2). We recently observed that, differently from conventional anti-inflammatory drugs, E(2) stimulates a nongenomic event that interferes with the LPS signal transduction from the plasma membrane to cytoskeleton and intracellular effectors, which results in the inhibition of the nuclear translocation of NF-kappaB, a transcription factor of inflammatory genes. Interference with NF-kappaB intracellular trafficking is selectively mediated by ER-alpha. In summary, evidence from basic research strongly indicates that the use of estrogenic drugs that can mimic the anti-inflammatory activity of E(2) might trigger beneficial effects against neurodegeneration in addition to carrying out their specific therapeutic function.
Similar articles
- Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection.
Cardona-Gómez GP, Mendez P, DonCarlos LL, Azcoitia I, Garcia-Segura LM. Cardona-Gómez GP, et al. Brain Res Brain Res Rev. 2001 Nov;37(1-3):320-34. doi: 10.1016/s0165-0173(01)00137-0. Brain Res Brain Res Rev. 2001. PMID: 11744097 Review. - Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration.
Chakrabarti M, Haque A, Banik NL, Nagarkatti P, Nagarkatti M, Ray SK. Chakrabarti M, et al. Brain Res Bull. 2014 Oct;109:22-31. doi: 10.1016/j.brainresbull.2014.09.004. Epub 2014 Sep 20. Brain Res Bull. 2014. PMID: 25245209 Free PMC article. Review. - From structural biochemistry to expression profiling: neuroprotective activities of estrogen.
Manthey D, Behl C. Manthey D, et al. Neuroscience. 2006;138(3):845-50. doi: 10.1016/j.neuroscience.2005.10.058. Epub 2005 Dec 15. Neuroscience. 2006. PMID: 16343783 Review. - Estrogen Formation and Inactivation Following TBI: What we Know and Where we Could go.
Duncan KA. Duncan KA. Front Endocrinol (Lausanne). 2020 May 29;11:345. doi: 10.3389/fendo.2020.00345. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32547495 Free PMC article. Review.
Cited by
- Considering the role of estradiol in the psychoneuroimmunology of perimenopausal depression.
Bondy E. Bondy E. Brain Behav Immun Health. 2024 Jul 21;40:100830. doi: 10.1016/j.bbih.2024.100830. eCollection 2024 Oct. Brain Behav Immun Health. 2024. PMID: 39161877 Free PMC article. - Association between dietary inflammatory index and cognitive impairment among American elderly: a cross-sectional study.
Zhang Y, Peng Y, Deng W, Xiang Q, Zhang W, Liu M. Zhang Y, et al. Front Aging Neurosci. 2024 Mar 14;16:1371873. doi: 10.3389/fnagi.2024.1371873. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38550747 Free PMC article. - Sex differences in pain along the neuraxis.
Presto P, Mazzitelli M, Junell R, Griffin Z, Neugebauer V. Presto P, et al. Neuropharmacology. 2022 Jun 1;210:109030. doi: 10.1016/j.neuropharm.2022.109030. Epub 2022 Mar 21. Neuropharmacology. 2022. PMID: 35331712 Free PMC article. Review. - Evaluation of S100A12 and Apo-A1 plasma level potency in untreated new relapsing-remitting multiple sclerosis patients and their family members.
Samangooei M, Farjam M, Etemadifar M, Taheri A, Meshkibaf MH, Movahedi B, Niknam Z, Noroozi S. Samangooei M, et al. Sci Rep. 2022 Feb 9;12(1):2160. doi: 10.1038/s41598-022-06322-4. Sci Rep. 2022. PMID: 35140322 Free PMC article. - Adverse childhood experiences interact with inflammation and menopause transition stage to predict verbal memory in women.
Metcalf CA, Johnson RL, Novick AM, Freeman EW, Sammel MD, Anthony LG, Epperson CN. Metcalf CA, et al. Brain Behav Immun Health. 2022 Jan 5;20:100411. doi: 10.1016/j.bbih.2022.100411. eCollection 2022 Mar. Brain Behav Immun Health. 2022. PMID: 35079709 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical